Wave Life Sciences (WVE) fell ~57% in the premarket on Thursday as Wall Street reacted to interim data from an early-stage trial for WVE-007, its RNA-based obesity medicine. Citing six-month follow-up ...
The post-pandemic bubble popped, but life sciences aren’t going anywhere. Blackstone announced Monday that it closed ...
Dialogue continues with European Medicines Agency (EMA) to advance the development program of oral blarcamesine in early Alzheimer’s ...
Of the 11 companies participating in the spring cohorts of the Drive program run by MassBio and SCbio, eight have locations ...
Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets ...
By Kamal Choudhury March 26 (Reuters) - Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its ...
W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...
Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences VI ("BXLS VI"). BXLS VI was oversubscribed ...
Overall, the 25 largest life science employers in Southern California have more than 28,000 employees combined.
As the life sciences and Medtech sectors undergo rapid transformation, new priorities are reshaping where companies choose to grow. A new report from the Hickey Institute explores the evolving ...
Ed Field is President of BioLabs NC. Mr. Field has 20+ years c-level experience in building and selling numerous early-stage and publicly-traded biotechnology companies. He has been responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results